General information

Announcements(2)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 16, 2026

Tue. Mar 17, 2026

Wed. Mar 18, 2026

web_header.png

web_icon.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts.<br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Profile management

Bookmark

Molecule to Medicine—Refining Human Prediction for Seamless Clinical Development

Drug development typically requires enormous costs and a period of more than 10 years, from the start of research and development to product launch and sales. During the drug development process, research and development is often abandoned due to various factors, including safety and pharmacokinetic issues and insufficient efficacy. For this reason, success rate is low and difficulty remains extremely high, just as it has in the past. However, pharmaceutical companies spare no effort to increase the success rate. At this symposium, researchers from leading pharmaceutical companies in Japan will talk about their efforts to introduce new in vitro evaluation methods through the introduction of New Approach Methods (NAMs), as well as their efforts to integrate rapidly advancing artificial intelligence (AI) and data science into actual research workflows.

The 99th Annual Meeting of the Japanese Pharmacological Society

Presentation Information

[2-CP-07]Molecule to Medicine—Refining Human Prediction for Seamless Clinical Development

Keywords:

Password required to view

Comment